← Back to Search

Text-Messaging (TM) for Coronavirus

N/A
Waitlist Available
Led By Guilherme Del Fiol, MD, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years.
Awards & highlights

Study Summary

This trial is testing two interventions to increase COVID-19 testing uptake in Utah Community Health Centers: Text Messaging and Patient Navigation. The goal is to find out which intervention is more effective in increasing testing uptake.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Uptake-Eligible
Secondary outcome measures
Reach PN-Engage
Reach-TM Engage
Total patients tested for COVID as indicated in health record out of total patient population in study. (Uptake-Total)

Trial Design

2Treatment groups
Active Control
Group I: Text-Messaging (TM)Active Control1 Intervention
Population health management intervention that analyzes electronic health record data to automatically identify participants with high risk for either infection or severe disease and proactivity reaches those participants via text message for testing needs (as advised by state and/or federal guidelines) and testing recommendation when applicable. This is a bi-directional text messaging system.
Group II: Text-Messaging plus Patient Navigation (TM+PN)Active Control2 Interventions
Population health management intervention that includes the same bi-directional text-messaging system as Arm 1 (the text messaging condition) with the addition of patient navigation. Patient navigation includes real-time assistance from a community health worker to address barriers, provide motivation, and assist with logistics of COIVD testing.

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
291,567 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,842,416 Total Patients Enrolled
Association for Utah Community HealthUNKNOWN
3 Previous Clinical Trials
194,301 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applicants still being accepted for this research endeavor?

"The clinical trial has not been actively recruiting since June 24th, 2022 according to the data found on clinicialtrials.gov. Despite this fact, there are currently 1,046 other studies that are still seeking participants for their medical trials."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers
David Wetter 2021. "SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04939532.
~27541 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top